Vertex Pharmaceuticals (VRTX) Tax Rate Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276.00 |
| Dec 31, 2025 | -2,150.00 |
| Sep 30, 2025 | 611.00 |
| Jun 30, 2025 | 2,101.00 |
| Mar 31, 2025 | 318.00 |
| Dec 31, 2024 | 582.00 |
| Sep 30, 2024 | -401.00 |
| Jun 30, 2024 | -2,422.00 |
| Mar 31, 2024 | -206.00 |
| Dec 31, 2023 | 460,862.00 |
| Sep 30, 2023 | 630.00 |
| Jun 30, 2023 | 1,639.00 |
| Mar 31, 2023 | 2,740.00 |
| Dec 31, 2022 | 1,483.00 |
| Sep 30, 2022 | -935.00 |
| Jun 30, 2022 | 867.00 |
| Mar 31, 2022 | 1,861.00 |
| Dec 31, 2021 | 4,828.00 |
| Sep 30, 2021 | 2,261.00 |
| Jun 30, 2021 | 35,219.00 |
| Mar 31, 2021 | 3,836.00 |
| Dec 31, 2020 | 3,019.00 |
| Sep 30, 2020 | 1,195.00 |
| Jun 30, 2020 | 1,427.00 |
| Mar 31, 2020 | 848.00 |
| Dec 31, 2019 | 1,499.00 |
| Sep 30, 2019 | 2,066.00 |
| Jun 30, 2019 | 1,869.00 |
| Mar 31, 2019 | 1,644.00 |
| Dec 31, 2018 | -458,613.00 |
| Sep 30, 2018 | 805.00 |
| Jun 30, 2018 | 581.00 |
| Mar 31, 2018 | -3,515.00 |
| Dec 31, 2017 | 578.00 |
| Sep 30, 2017 | 44,799.00 |
| Jun 30, 2017 | 15,149.00 |
| Mar 31, 2017 | 154.00 |
| Dec 31, 2016 | -4,745.00 |
| Sep 30, 2016 | 1,259.00 |